Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2015 Oct;17(10):777-82.
doi: 10.1111/jch.12614. Epub 2015 Jul 14.

Independent Determinants of Maternal and Fetal Outcomes in a Sample of Pregnant Outpatients With Normal Blood Pressure, Chronic Hypertension, Gestational Hypertension, and Preeclampsia

Affiliations
Comparative Study

Independent Determinants of Maternal and Fetal Outcomes in a Sample of Pregnant Outpatients With Normal Blood Pressure, Chronic Hypertension, Gestational Hypertension, and Preeclampsia

Arrigo F G Cicero et al. J Clin Hypertens (Greenwich). 2015 Oct.

Abstract

The aim of this retrospective study was to evaluate the main independent prognostic factors of negative maternal and fetal outcomes in a relatively large sample of pregnant outpatients (N=906) who were normotensive or affected by chronic hypertension, gestational hypertension, or preeclampsia. Among the studied parameters, the ones significantly associated with negative maternal outcomes were a diagnosis of preeclampsia (vs other forms of hypertension or normotension) and higher serum uric acid level, while antihypertensive treatment, number of previous deliveries, and blood pressure (BP) control at deliveries seemed to be protective. Regarding negative fetal outcomes, the parameters significantly associated with a negative maternal outcome were a diagnosis of preeclampsia (vs other forms of hypertension or normotension) and mother pre-pregnancy body mass index, while antihypertensive treatment and BP control at delivery seemed to be protective. Specific patient characteristics should help to predict the risk of negative maternal and fetal outcomes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart showing patient selection. Distribution of number of pregnancies by hypertension group. CRF indicates clinical report form.
Figure 2
Figure 2
Systolic blood pressure (SBP) (A) and diastolic blood pressure (DBP) (B) trend in the different considered groups of women during pregnancy and at delivery. Distribution of antihypertensive drug prescription among different hypertensive patient groups. PE indicates preeclampsia; G‐HT, gestational hypertension; C‐HT, chronic hypertension; NT, normotensive.

Comment in

Similar articles

Cited by

References

    1. Magee LA, Abalos E, von Dadelszen P, et al. How to manage Hypertension in pregnancy effectively. Br J Clin Pharmacol. 2011;72:394–401. - PMC - PubMed
    1. National Collaborating Centre for Women's and Children's Health (UK) . Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. National Institute for Health and Clinical Excellence: Guidance. RCOG Press: London, England; 2010:46. - PubMed
    1. Regitz‐Zagrosek V, BlomstromLundqvist C, Borghi C, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:3147–3197. - PubMed
    1. Khan KS, Wojdyla D, Say L, et al. WHO Analysis of cause of maternal death: a systematic review. Lancet. 2006;367:1066–1074. - PubMed
    1. Chandiramani M, Shennan A. Hypertensive disorders of pregnancy: a UK‐based perspective. Curr Opin Obstet Gynecol. 2008;20:96–101. - PubMed

Publication types

MeSH terms